Strain and dynamic measurements using fiber optic sensors embedded into graphite/epoxy tubes

Graphite/epoxy tubes were fabricated with embedded optical fibers to evaluate the feasibility of monitoring strains with a fiber optic technique. Resistance strain gauges were attached to the tubes to measure strain at four locations along the tube for comparison with the fiber optic sensors. Both static and dynamic strain measurements were made with excellent agreement between the embedded fiber optic strain sensor and the strain gauges. Strain measurements of 10(exp -7) can be detected with the optical phase locked loop (OPLL) system using optical fiber. Because of their light weight, compatibility with composites, immunity to electromagnetic interference, and based on the static and dynamic results obtained, fiber optic sensors embedded in composites may be useful as the sensing component of smart structures

Estimativas de herdabilidade e correlações para escores visuais, peso e altura ao sobreano em rebanhos da raça Nelore.

Os objetivos neste trabalho foram avaliar as relações entre os escores visuais de estrutura corporal, precocidade e musculosidade ao sobreano (aproximadamente 550 dias de idade) com características de crescimento para verificar as possibilidades de utilizar essas características como critérios de seleção. Foram obtidas estimativas dos componentes de covariâncias por máxima verossimilhança restrita empregando-se um modelo animal com o efeito fixo de grupo contemporâneo e a idade como covariável (efeitos linear e quadrático). Os grupos contemporâneos foram definidos pelas variáveis: sexo; ano, estação e fazenda de nascimento; e fazenda e grupo de manejo aos 120, 210, 365 e 550 dias de idade. Foram utilizadas 1.367 observações de estrutura corporal, precocidade e musculosidade. As estimativas de herdabilidade foram de 0,24 ± 0,09 para estrutura corporal; 0,63 ± 0,12 para precocidade e 0,48 ± 0,11 para musculosidade, e as estimativas de correlações genéticas entre os escores foram 0,49 entre estrutura corporal e precocidade; 0,63 entre estrutura corporal e musculosidade; e 0,90 entre precocidade e musculosidade. As correlações genéticas entre os escores de estrutura corporal, precocidade e musculosidade, e o peso ao sobreano foram todas positivas (0,83; 0,42 e 0,50, respectivamente), enquanto as estimativas de correlações genéticas entre altura de posterior e os escores de estrutura corporal, precocidade e musculosidade, respectivamente, foram 0,57, -0,29 e -0,33. As características estrutura corporal, precocidade e musculosidade ao sobreano apresentaram variação genética aditiva de moderada a alta. As correlações genéticas dos escores com altura do posterior indicam que a seleção de animais mais altos, ainda que indireta, pode ocasionar aumento da estrutura corporal média dos animais, que poderão ser menos precoces e menos musculosos ao sobreano. A seleção para os escores visuais, principalmente para estrutura corporal, deve promover aumento no peso ao sobreano dos animais.Meta de 2010

Desempenho de reprodutores jovens da Raça Nelore em teste de performance a pasto no Acre.

O objetivo deste trabalho foi avaliar a eficiência do teste de performance a pasto da raça Nelore no Acre e do índice de seleção utilizado em discriminar grupos de tourinhos geneticamente superiores a serem adotados para melhoria dos indicadores de eficiência e rentabilidade dos sistemas de produção de carne tradicionais do estado.bitstream/item/209142/1/26944.pd

Reference Percentiles for Bioelectrical Phase Angle in Athletes

The present study aimed to develop reference values for bioelectrical phase angle in male and female athletes from different sports. Overall, 2224 subjects participated in this study [1658 males (age 26.2±8.9 y) and 566 females (age 26.9±6.6 y)]. Participants were categorized by their sport discipline and sorted into three different sport modalities: Endurance, velocity/power, and team sports. Phase angle was directly measured using a foot-to-hand bioimpedance technology at a 50 kHz frequency during the in-season period. Reference percentiles (5th, 15th, 50th, 85th, and 95th) were calculated and stratified by sex, sport discipline and modality using an empirical Bayesian analysis. This method allows for the sharing of information between different groups, creating reference percentiles, even for sports disciplines with few observations. Phase angle differed (men: P<0.001; women: P=0.003) among the three sport modalities, where endurance athletes showed a lower value than the other groups (men: Vs. velocity/power: P=0.010, 95% CI=−0.43 to −0.04; vs. team sports: P < 0.001, 95% CI=−0.48 to −0.02; women: Vs. velocity/power: P=0.002, 95% CI=−0.59 to −0.10; vs. team sports: P=0.015, 95% CI=−0.52 to−0.04). Male athletes showed a higher phase angle than female athletes within each sport modality (endurance: p<0.01, 95% CI=0.63 to 1.14; velocity/power: P<0.01, 95% CI=0.68 to 1.07; team sports: P<0.01, 95% CI=0.98 to 1.23). We derived phase angle reference percentiles for endurance, velocity/power, and team sports athletes. Additionally, we calculated sex-specific references for a total of 22 and 19 sport disciplines for male and female athletes, respectively. This study provides sex and sport-specific percentiles for phase angle that can track body composition and performance-related parameters in athletes

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

Peginterferon plus ribavirin achieves sustained virological response (SVR) in fewer than half of patients with genotype 1 chronic hepatitis C virus infection treated for 48 weeks. We tested the efficacy of boceprevir, an NS3 hepatitis C virus oral protease inhibitor, when added to peginterferon alfa-2b and ribavirin. In part 1 of this trial, undertaken in 67 sites in the USA, Canada, and Europe, 520 treatment-naive patients with genotype 1 hepatitis C virus infection were randomly assigned to receive peginterferon alfa-2b 1·5 μg/kg plus ribavirin 800–1400 mg daily for 48 weeks (PR48; n=104); peginterferon alfa-2b and ribavirin daily for 4 weeks, followed by peginterferon alfa-2b, ribavirin, and boceprevir 800 mg three times a day for 24 weeks (PR4/PRB24; n=103) or 44 weeks (PR4/PRB44; n=103); or peginterferon alfa-2b, ribavirin, and boceprevir three times a day for 28 weeks (PRB28; n=107) or 48 weeks (PRB48; n=103). In part 2, 75 patients were randomly assigned to receive either PRB48 (n=16) or low-dose ribavirin (400–1000 mg) plus peginterferon alfa-2b and boceprevir three times a day for 48 weeks (low-dose PRB48; n=59). Randomisation was by computer-generated code, and study personnel and patients were not masked to group assignment. The primary endpoint was SVR 24 weeks after treatment. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00423670. Patients in all four boceprevir groups had higher rates of SVR than did the control group (58/107 [54%, 95% CI 44–64], p=0·013 for PRB28; 58/103 [56%, 44–66], p=0·005 for PR4/PRB24; 69/103 [67%, 57–76], p<0·0001 for PRB48; and 77/103 [75%, 65–83], p<0·0001 for PR4/PRB44; vs 39/104 [38%, 28–48] for PR48 control). Low-dose ribavirin was associated with a high rate of viral breakthrough (16/59 [27%]), and a rate of relapse (six of 27 [22%]) similar to control (12/51 [24%]). Boceprevir-based groups had higher rates of anaemia (227/416 [55%] vs 35/104 [34%]) and dysgeusia (111/416 [27%] vs nine of 104 [9%]) than did the control group. In patients with untreated genotype 1 chronic hepatitis C infection, the addition of the direct-acting antiviral agent boceprevir to standard treatment with peginterferon and ribavirin after a 4-week lead-in seems to have the potential to double the sustained response rate compared with that recorded with standard treatment alone. Merck

Negative Autoregulation by Fas Stabilizes Adult Erythropoiesis and Accelerates Its Stress Response

Erythropoiesis maintains a stable hematocrit and tissue oxygenation in the basal state, while mounting a stress response that accelerates red cell production in anemia, blood loss or high altitude. Thus, tissue hypoxia increases secretion of the hormone erythropoietin (Epo), stimulating an increase in erythroid progenitors and erythropoietic rate. Several cell divisions must elapse, however, before Epo-responsive progenitors mature into red cells. This inherent delay is expected to reduce the stability of erythropoiesis and to slow its response to stress. Here we identify a mechanism that helps to offset these effects. We recently showed that splenic early erythroblasts, ‘EryA’, negatively regulate their own survival by co-expressing the death receptor Fas, and its ligand, FasL. Here we studied mice mutant for either Fas or FasL, bred onto an immune-deficient background, in order to avoid an autoimmune syndrome associated with Fas deficiency. Mutant mice had a higher hematocrit, lower serum Epo, and an increased number of splenic erythroid progenitors, suggesting that Fas negatively regulates erythropoiesis at the level of the whole animal. In addition, Fas-mediated autoregulation stabilizes the size of the splenic early erythroblast pool, since mutant mice had a significantly more variable EryA pool than matched control mice. Unexpectedly, in spite of the loss of a negative regulator, the expansion of EryA and ProE progenitors in response to high Epo in vivo, as well as the increase in erythropoietic rate in mice injected with Epo or placed in a hypoxic environment, lagged significantly in the mutant mice. This suggests that Fas-mediated autoregulation accelerates the erythropoietic response to stress. Therefore, Fas-mediated negative autoregulation within splenic erythropoietic tissue optimizes key dynamic features in the operation of the erythropoietic network as a whole, helping to maintain erythroid homeostasis in the basal state, while accelerating the stress response

A Key Commitment Step in Erythropoiesis Is Synchronized with the Cell Cycle Clock through Mutual Inhibition between PU.1 and S-Phase Progression

During red blood cell development, differentiation and cell cycle progression are intimately and uniquely linked through interdependent mechanisms involving the erythroid transcriptional suppressor PU.1 and the cyclin-dependent kinase inhibitor p57KIP2

Upregulation of Hemoglobin Expression by Oxidative Stress in Hepatocytes and Its Implication in Nonalcoholic Steatohepatitis

Recent studies revealed that hemoglobin is expressed in some non-erythrocytes and it suppresses oxidative stress when overexpressed. Oxidative stress plays a critical role in the pathogenesis of non-alcoholic steatohepatitis (NASH). This study was designed to investigate whether hemoglobin is expressed in hepatocytes and how it is related to oxidative stress in NASH patients. Analysis of microarray gene expression data revealed a significant increase in the expression of hemoglobin alpha (HBA1) and beta (HBB) in liver biopsies from NASH patients. Increased hemoglobin expression in NASH was validated by quantitative real time PCR. However, the expression of hematopoietic transcriptional factors and erythrocyte specific marker genes were not increased, indicating that increased hemoglobin expression in NASH was not from erythropoiesis, but could result from increased expression in hepatocytes. Immunofluorescence staining demonstrated positive HBA1 and HBB expression in the hepatocytes of NASH livers. Hemoglobin expression was also observed in human hepatocellular carcinoma HepG2 cell line. Furthermore, treatment with hydrogen peroxide, a known oxidative stress inducer, increased HBA1 and HBB expression in HepG2 and HEK293 cells. Importantly, hemoglobin overexpression suppressed oxidative stress in HepG2 cells. We concluded that hemoglobin is expressed by hepatocytes and oxidative stress upregulates its expression. Suppression of oxidative stress by hemoglobin could be a mechanism to protect hepatocytes from oxidative damage in NASH